Pycnogenol® in Post-COVID-19 Condition
NCT05890534
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
153
Enrollment
OTHER
Sponsor class
Conditions
Post COVID-19 Condition
Long COVID
Interventions
DRUG:
Pycnogenol®
DRUG:
Placebo
Sponsor
University of Zurich